Psychische Erkrankungen in der Lebensspanne ... - DGPPN
Psychische Erkrankungen in der Lebensspanne ... - DGPPN
Psychische Erkrankungen in der Lebensspanne ... - DGPPN
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Topic 12 G Bildgebung, Neurophysiologie, Neuropsychologie // Bra<strong>in</strong> Imag<strong>in</strong>g, neurophysiology, neuropsychology<br />
of dementia with more than 70 % accuracy. Automated high-resolution<br />
image process<strong>in</strong>g us<strong>in</strong>g deformation based morphometry<br />
together with multivariate analysis predicts of onset of dementia <strong>in</strong><br />
at risk stages with more than 80 % accuracy. Functional MRI <strong>in</strong> the<br />
rest<strong>in</strong>g state may evolve as easily accessible marker of cortical functional<br />
connectivity, but requires further study. Detection of subcortical<br />
fiber tract <strong>in</strong>tegrity may be a useful adjunct to functional and<br />
structural imag<strong>in</strong>g, but has not yet fully been explored as diagnostic<br />
or outcome marker. F<strong>in</strong>ally, new <strong>in</strong> vivo tracer of amyloid plaque<br />
load with positron emission tomography may identify amyloid pathology<br />
<strong>in</strong> asymptomatic subjects as risk marker of AD and may be<br />
useful to detect effects of amyloid lower<strong>in</strong>g treatment strategies <strong>in</strong><br />
vivo.<br />
Discussion / Results: Multimodal imag<strong>in</strong>g draws a comprehensive<br />
picture of amyloid pathology, cortical connectivity and neuroanl<br />
degeneration and will be important <strong>in</strong> the near future to enhance<br />
the power of cl<strong>in</strong>ical prevention trials and to better un<strong>der</strong>stand the<br />
effect of amyloid pathology on cognitive decl<strong>in</strong>e. The broad implementation<br />
of advanced neuroimag<strong>in</strong>g techniques <strong>in</strong> cl<strong>in</strong>ical rout<strong>in</strong>e,<br />
however, very likely will depend on the availability of next generation<br />
treatment approaches that aim to modify un<strong>der</strong>ly<strong>in</strong>g<br />
disease processes.<br />
002<br />
Neuroimag<strong>in</strong>g <strong>in</strong> neuropsychiatric disor<strong>der</strong>s: differential diagnosis<br />
and prediction of cl<strong>in</strong>ical course<br />
Oliver Pogarell (LMU München, Kl<strong>in</strong>ik für Psychiatrie)<br />
Introduction: The neurobiological characterisation of psychiatric<br />
disor<strong>der</strong>s provides <strong>in</strong>sight <strong>in</strong>to bra<strong>in</strong> functional alterations and relevant<br />
pathomechanisms, and is a major issue of current research.<br />
Nowadays there is <strong>in</strong>creas<strong>in</strong>g evidence that neurobiological parameters<br />
can be used as diagnostic tools and to warrant or to validate<br />
pharmacological treatment decisions. Clear pathophysiological hypotheses<br />
with respect to neuronal activity or bra<strong>in</strong> neurochemistry<br />
provide a scientific basis for the development of differential treatment<br />
strategies and the evaluation of the course of the disor<strong>der</strong> un<strong>der</strong><br />
treatment. Thus the assessment of bra<strong>in</strong> activity at rest or upon<br />
stimulation <strong>in</strong>clud<strong>in</strong>g un<strong>der</strong>ly<strong>in</strong>g neurochemical alterations can<br />
help to facilitate the differential diagnosis and subsequent therapeutic<br />
decisions.<br />
Method: Neurophysiology and neuroimag<strong>in</strong>g are the key tools to<br />
evaluate bra<strong>in</strong> functional disor<strong>der</strong>s and consequently to monitor<br />
neurobiological treatment effects. In particular, a comb<strong>in</strong>ation of<br />
complementary methods can add to the cl<strong>in</strong>ical assessment of psychopathology<br />
with respect to differential diagnoses and treatment<br />
decisions. Furthermore, these methods help to prove pathophysiological<br />
concepts.<br />
Discussion / Results: Both neurophysiological and functional neuroimag<strong>in</strong>g<br />
techniques have been used to discrim<strong>in</strong>ate diagnostic<br />
and therapeutic subgroups of neuropsychiatric patients and have<br />
been assessed regard<strong>in</strong>g prognostic and predictive properties. Studies<br />
<strong>in</strong> patients with depression, obsessive compulsive disor<strong>der</strong>, attention<br />
deficit or emotional <strong>in</strong>stability provide evidence of different<br />
pathophysiological mechanisms of both categories of psychiatric<br />
disor<strong>der</strong>s and psychopathological dimensions. Therefore the data<br />
might be useful <strong>in</strong> cl<strong>in</strong>ical application – <strong>in</strong> terms of diagnosis, evaluation<br />
of the course or prediction of subjects‘ responses to treatment.<br />
003<br />
Neuroimag<strong>in</strong>g <strong>in</strong> major psychosis: neuromarkers for validation<br />
and reformation of psychiatric classification systems<br />
Oliver Gruber (Universitätskl<strong>in</strong>ikum Gött<strong>in</strong>gen, Kl<strong>in</strong>ik für Psychiatrie)<br />
Introduction: In psychiatric research, neuroimag<strong>in</strong>g techniques<br />
are usually applied <strong>in</strong> or<strong>der</strong> to detect morphological and / or functional<br />
(i. e. pathophysiological) bra<strong>in</strong> abnormalities <strong>in</strong> patient<br />
groups. These group abnormalities may either be common to different<br />
psychiatric disor<strong>der</strong>s, e. g. to different types of major psychoses<br />
(schizophrenia, schizoaffective disor<strong>der</strong>, bipolar disor<strong>der</strong> and unipolar<br />
major depression), or they may be specific to one of these<br />
diag nostic categories accord<strong>in</strong>g to current classifications systems,<br />
which could help to confirm the biological validity of these diagnoses.<br />
On the other hand, the same neuroimag<strong>in</strong>g techniques can<br />
also be used <strong>in</strong> or<strong>der</strong> to search for neuromarkers that may be common<br />
to subgroups of patients <strong>in</strong>dependent of their diagnosis<br />
accord <strong>in</strong>g to current classification. If this approach of def<strong>in</strong><strong>in</strong>g <strong>in</strong>termediate<br />
psychiatric phenotypes accord<strong>in</strong>g to neuropathophysiological<br />
markers proves to be successful, this could advance the<br />
identification of pathogenetic pathways and could lead to a reformation<br />
of diagnostic systems based on etiology and pathogenesis.<br />
Method: Different methods may contribute to category-<strong>in</strong>dependent<br />
search for endophenotypic neuropathophysiological markers<br />
us<strong>in</strong>g neuroimag<strong>in</strong>g. Statistical analyses of, for <strong>in</strong>stance, bra<strong>in</strong> activation<br />
abnormalities <strong>in</strong> s<strong>in</strong>gle patients may be a first step <strong>in</strong> the<br />
attempt to identify subgroups of patients with a more homogeneous<br />
un<strong>der</strong>ly<strong>in</strong>g pathophysiology. More advanced methods <strong>in</strong>clude<br />
pattern classification and related approaches.<br />
Discussion / Results: There is already ample evidence for neurobiological<br />
heterogeneity with<strong>in</strong> the diagnostic categories accord<strong>in</strong>g<br />
to current psychiatric classification systems. In this talk, examples<br />
for this heterogeneity will be <strong>in</strong>troduced with particular emphasis<br />
on neuroimag<strong>in</strong>g f<strong>in</strong>d<strong>in</strong>gs. Furthermore, recent examples for the<br />
success of pattern classification methods <strong>in</strong> detect<strong>in</strong>g common<br />
neuropathophysiological markers <strong>in</strong> neuroimag<strong>in</strong>g data will be<br />
presented. In or<strong>der</strong> to further evaluate the possible diagnostic value<br />
of neuroimag<strong>in</strong>g markers with regard to future psychiatric diagnosis<br />
based on etiology and pathogenesis it will also be important to<br />
acquire normative data on these neuromarkers.<br />
004<br />
Neuroimag<strong>in</strong>g <strong>in</strong> depression and schizophrenia: evaluation of therapeutic<br />
approaches<br />
Ute Habel (Universitätskl<strong>in</strong>ik Aachen, Psychiatrie und Psychotherapie)<br />
Introduction: Neuropsychological as well as neuroimag<strong>in</strong>g data<br />
reveal a complex dysfunctional <strong>in</strong>teraction <strong>in</strong> schizophrenia but<br />
also <strong>in</strong> depressive patients, where especially subcortical-limbic but<br />
also frontal and c<strong>in</strong>gular regions show aberrant activation patterns<br />
dur<strong>in</strong>g cognitive as well as emotional functions. Hence, regions of<br />
major importance <strong>in</strong> cognition but also emotion regulation and<br />
<strong>in</strong>te gration are affected.<br />
Method: Longitud<strong>in</strong>al fMRI studies evaluate the possibility to reduce<br />
cognitive and emotional impairments with specific psychological<br />
therapies. In schizophrenia, a cognitive tra<strong>in</strong><strong>in</strong>g was evaluated<br />
as well as an emotion recognition tra<strong>in</strong><strong>in</strong>g. In depression a standardized<br />
humor tra<strong>in</strong><strong>in</strong>g has been evaluated on the dysfunctional correlates<br />
dur<strong>in</strong>g humorour cartoon process<strong>in</strong>g.<br />
Discussion / Results: A complex pattern of hypo- and hyperactivations<br />
emerged <strong>in</strong> a subcortical-limbic as well as cortical network <strong>in</strong><br />
dependence of task requirements. Results of the longitud<strong>in</strong>al studies<br />
document the therapeutic effects, normally seen on a behavioral<br />
level, <strong>in</strong> the un<strong>der</strong>ly<strong>in</strong>g neuronal substrates and demonstrate the<br />
specific efficacy of behavioral therapies. However, concern<strong>in</strong>g psy-<br />
267